Noumena Analysis (@gilamonstrum) 's Twitter Profile
Noumena Analysis

@gilamonstrum

Pharmacist
PhD candidate

ID: 1494036559502401539

linkhttp://Noumena.tech calendar_today16-02-2022 19:51:01

792 Tweet

1,1K Takipçi

92 Takip Edilen

Noumena Analysis (@gilamonstrum) 's Twitter Profile Photo
Noumena Analysis
@gilamonstrum

4 months ago

At first glance $LLY orforglipron seems to outperform $GPCR aleniglipron, at least based on P2 and P3 data in T2D patients. Based on cross-trial comparisons, orfo induces better glycaemic control (0.4% is the superiority threshold for A1c), better weight loss and a more favorable

At first glance $LLY orforglipron seems to outperform $GPCR aleniglipron, at least based on P2 and P3 data in T2D patients. Based on cross-trial comparisons, orfo induces better glycaemic control (0.4% is the superiority threshold for A1c), better weight loss and a more favorable